(f) the denominations in which Securities of the series shall be issuable;
(g) the coin or currency in which the Securities of that series are denominated or in which principal, premium, if any,
and interest, if any, are payable;
(h) the date or dates on which the principal and premium of the Securities of that
series, if any and to the extent applicable, are payable;
(i) the rate or rates (which may be fixed or variable) at which
the Securities of the series shall bear interest, and the manner of calculating such rate or rates, if applicable;
(j) the
date or dates from which such interest, if any and to the extent applicable, shall accrue, the interest payment dates on which such interest shall be payable and the record dates (in the case of Registered Securities) for the determination of
Holders to whom interest is payable and/or the method by which such or date or dates shall be determined;
(k) if the
amount of payments of principal or any premium or interest on the Securities of the series may be determined with reference to a formula or an index, including, but not limited to, an index based on a coin or currency other than that in which the
Securities of the series are denominated, or with reference to any currencies, securities or baskets of securities, commodities or indices, the manner in which such amounts shall be determined, to the extent permitted under applicable regulatory
capital or other requirements of the FSA or other applicable regulatory authority;
(l) the manner in which and the place
or places where, if applicable, the principal of, premium of and any interest on the Securities of the series shall be payable (subject to the provisions of Section 3.02);
(m) the right or requirement, if any, to extend the interest payment periods or cancel the payment of interest and the duration
and effect of that extension or cancellation;
(n) any terms required by or advisable under applicable laws or regulations
or rating agency criteria, including laws and regulations relating to attributes required for the Securities to qualify as capital or certain liabilities for regulatory, rating or other purposes;
(o) if applicable, any modification or elimination of any covenants or conditions or events that would constitute breaches with
respect to the Securities of such series;
(p) any conversion or exchange features of the Securities;
(q) whether and under what circumstances the Company will pay Additional Amounts on the Securities for any tax, assessment or
governmental charge withheld or deducted and, if so, whether it will have the option to redeem those Securities rather than pay the Additional Amounts, to the extent permitted under applicable regulatory capital or other requirements of the FSA or
other applicable regulatory authority;
(r) the period or periods within which, the price or prices at which, and the terms
and conditions upon which Securities of the series may be redeemed, in whole or in part, at the option of the Company, to the extent permitted under applicable regulatory capital or other requirements of the FSA or other applicable regulatory
authority;
(s) the identity of any agents for the Securities, including trustees, depositaries, authenticating,
calculating or paying agents, transfer agents or registrars or any clearing organization for any series;
(t) any
restrictions applicable to the offer, sale or delivery of the Securities;
(u) any provisions for the discharge of the
Companys obligations relating to the Securities;
(v) material U.S. federal or Japanese tax considerations;
(w) if the Securities of such series are to be issuable in definitive form (whether upon original issue or upon exchange of a
temporary Security of such series) only upon receipt of certain certificates or other documents or satisfaction of other conditions, the form and terms of such certificates, documents or conditions;
10